Literature DB >> 17982690

Microarray analysis of insulin-regulated gene expression in the liver: the use of transgenic mice co-expressing insulin-siRNA and human IDE as an animal model.

Seungwan Jee1, Daeyoun Hwang, Sujin Seo, Yongkyu Kim, Chuelkyu Kim, Byungguk Kim, Sunbo Shim, Suhae Lee, Jisoon Sin, Changjun Bae, Byoungchun Lee, Meekyung Jang, Minsun Kim, Suyoun Yim, Insurk Jang, Jungsik Cho, Kabryong Chae.   

Abstract

To characterize the changes in global gene expression in the livers of H1/siRNAinsulin-CMV/hIDE transgenic (Tg) mice in response to the reduced bioavailability of insulin, total RNA extracted from the livers of 20-week-old Tg and non-Tg mice was converted to cDNA, labeled with biotin and hybridized to oligonucleotide microarrays. The microarray results were confirmed by a real-time reverse transcription-polymerase chain reaction. Two hundred and fifty-one and 73 genes were up- and down-regulated, respectively by insulin in H1/siRNAinsulin-CMV/hIDE Tg mice compared to the controls. Genes encoding for physiological processes, extracellular defense response and response to biotic stimuli were significantly over-represented in the up-regulated group. Among the down-regulated transcripts, those encoding for extracellular matrix proteins were dramatically over-represented, followed by those related to monooxygenase and oxidoreductase activities. The major genes in the up-regulated categories included Egr1, Saa2, Atf3, DNAJB1 and cCL2, whereas those in the down-regulated categories were Cyp17a1, Adn, Gadd45g, Eno3 and Moxd1. These results indicate that the microarray analysis identifies several gene functional groups and individual genes that respond to a sustained reduction in the insulin levels in the livers of Tg mice. These results also suggest that microarray testing is a useful tool for the better understanding of insulin-regulated diabetes-related diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982690

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  6 in total

1.  Early growth response 1 (Egr1) regulates cholesterol biosynthetic gene expression.

Authors:  Nolan G Gokey; Camila Lopez-Anido; Anne Lynn Gillian-Daniel; John Svaren
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

2.  Microarray analysis of genes with impaired insulin regulation in the skeletal muscle of type 2 diabetic patients indicates the involvement of basic helix-loop-helix domain-containing, class B, 2 protein (BHLHB2).

Authors:  S Rome; E Meugnier; V Lecomte; V Berbe; J Besson; C Cerutti; S Pesenti; A Granjon; E Disse; K Clement; E Lefai; M Laville; H Vidal
Journal:  Diabetologia       Date:  2009-07-10       Impact factor: 10.122

3.  Gadd45 in the Liver: Signal Transduction and Transcriptional Mechanisms.

Authors:  Jianmin Tian; Joseph Locker
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Structure, function, and regulation of insulin-degrading enzyme.

Authors:  Raymond E Hulse; Luis A Ralat; Tang Wei-Jen
Journal:  Vitam Horm       Date:  2009       Impact factor: 3.421

5.  Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome.

Authors:  Michelle R Jones; Angela Chua; Yii-Der I Chen; Xiaohui Li; Ronald M Krauss; Jerome I Rotter; Richard S Legro; Ricardo Azziz; Mark O Goodarzi
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

6.  Investigation of the Tissue Distribution and Physiological Roles of Indoleamine 2,3-Dioxygenase-2.

Authors:  Felicita F Jusof; Supun M Bakmiwewa; Silvia Weiser; Lay Khoon Too; Richard Metz; George C Prendergast; Stuart T Fraser; Nicholas H Hunt; Helen J Ball
Journal:  Int J Tryptophan Res       Date:  2017-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.